Feng Cong, Wang Libo, Huang Sai, Xing Qinrui, Zhou Xuan, Xing Ning, Lv Faqin, Li Tanshi
Department of Emergency, First Medical Center, General Hospital of the PLA, Beijing, China.
Department of Ultrasound, Hainan Hospital of the PLA General Hospital, Sanya, China.
Ann Transl Med. 2021 Feb;9(4):307. doi: 10.21037/atm-20-4426.
Multimodal fusion imaging (MMFI) was usually used to assist percutaneous procedures for difficult lesions, with most applications occurring with hepatic and prostatic interventions. This paper aimed to evaluate the precision and effectiveness of computed tomography-ultrasound (CT-US) fusion imaging (CUFI)-assisted US-guided percutaneous intervention (UGPI) in early local drug therapy for pancreatic contusion and laceration (PCL).
A total of 12 pigs with PCL were randomly divided into a CUFI-assisted UGPI (MU) group (n=6) and a single UGPI (SU) group (n=6). The MU group underwent CUFI-assisted UGPI of locally applied medical protein glue (1 mL) injection while the SU group received the same therapy using two-dimensional UGPI. The duration and accuracy of each procedure were observed in the 2 groups.
In the MU group, the overall time of the procedure for locking the plane was 1.85±0.06 minutes. Less time was spent in the selection of the pathway and puncture site in the MU group compared with the SU group (6.56±0.42 7.61±0.44 minutes, P<0.01). The duration of puncturing and drug injection was also shorter in the MU group than in the SU group (3.41±0.30 4.20±0.20 minutes, P<0.01) and the MU group had a higher accuracy of medical protein glue injection than the SU group (100% 50%, P<0.05).
CUFI could increase the precision and effectiveness of early UGPI in the delivery of local drug therapy in PCL.
多模态融合成像(MMFI)通常用于辅助对困难病变进行经皮手术,大多数应用发生在肝脏和前列腺介入手术中。本文旨在评估计算机断层扫描-超声(CT-US)融合成像(CUFI)辅助的超声引导经皮介入(UGPI)在胰腺挫伤和裂伤(PCL)早期局部药物治疗中的准确性和有效性。
将12只患有PCL的猪随机分为CUFI辅助UGPI(MU)组(n = 6)和单纯UGPI(SU)组(n = 6)。MU组接受CUFI辅助的局部注射医用蛋白胶(1 mL)的UGPI,而SU组使用二维UGPI接受相同治疗。观察两组中每个手术的持续时间和准确性。
在MU组中,锁定平面的整个手术时间为1.85±0.06分钟。与SU组相比,MU组在选择路径和穿刺部位上花费的时间更少(6.56±0.42对7.61±0.44分钟,P<0.01)。MU组的穿刺和药物注射持续时间也比SU组短(3.41±0.30对4.20±0.20分钟,P<0.01),并且MU组医用蛋白胶注射的准确性高于SU组(100%对50%,P<0.05)。
CUFI可以提高早期UGPI在PCL局部药物治疗中的准确性和有效性。